Drug Shortage Report for HALOPERIDOL INJECTION
Report ID | 109771 |
Drug Identification Number | 02366010 |
Brand name | HALOPERIDOL INJECTION |
Common or Proper name | Haloperidol Injection |
Company Name | OMEGA LABORATORIES LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | HALOPERIDOL |
Strength(s) | 5MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAMUSCULAR |
Packaging size | 10 x 1mL vial / fiole |
ATC code | N05AD |
ATC description | ANTIPSYCHOTICS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2020-03-17 |
Estimated end date | Unknown |
Actual end date | 2020-06-08 |
Shortage status | Resolved |
Updated date | 2020-06-09 |
Company comments | Preventive Allocation (COVID-19) |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 11177 HAMON MONTREAL, QUEBEC CANADA H3M 3E4 |
Company contact information | info@omegalaboratory.com - 1-800-363-0584 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2020-06-09 | English | Compare |
v4 | 2020-06-05 | French | Compare |
v3 | 2020-06-05 | English | Compare |
v2 | 2020-03-30 | French | Compare |
v1 | 2020-03-30 | English | Compare |
Showing 1 to 5 of 5